| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are recombinant gonadotrophins safer, purer and more effective than urinary gonadotrophins?
|
Casper, Robert F
|
|
2005
|
11 |
5 |
p. 539-540
2 p.
|
artikel
|
| 2 |
Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination
|
Kuwayama, Masashige
|
|
2005
|
11 |
5 |
p. 608-614
7 p.
|
artikel
|
| 3 |
Cost restricts the value of recombinant FSH
|
Felberbaum, Ricardo
|
|
2005
|
11 |
5 |
p. 544-
1 p.
|
artikel
|
| 4 |
Cryosystem assessment by glucose uptake of murine blastocysts
|
Walker, David
|
|
2005
|
11 |
5 |
p. 601-607
7 p.
|
artikel
|
| 5 |
Effects of peritoneal fluid on preimplantation mouse embryo development and apoptosis in vitro
|
Esfandiari, Navid
|
|
2005
|
11 |
5 |
p. 615-619
5 p.
|
artikel
|
| 6 |
Ethical issues in paying for long-distance travel and accommodation expenses of oocyte donors
|
Heng, Boon Chin
|
|
2005
|
11 |
5 |
p. 552-553
2 p.
|
artikel
|
| 7 |
Factors influencing response to ovarian stimulation
|
Keck, Christoph
|
|
2005
|
11 |
5 |
p. 562-569
8 p.
|
artikel
|
| 8 |
FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level?
|
Dorn, Christoph
|
|
2005
|
11 |
5 |
p. 555-561
7 p.
|
artikel
|
| 9 |
Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?
|
Nawroth, Frank
|
|
2005
|
11 |
5 |
p. 581-588
8 p.
|
artikel
|
| 10 |
Impact of androgens on fertility – physiological, clinical and therapeutic aspects
|
Hugues, J-N
|
|
2005
|
11 |
5 |
p. 570-580
11 p.
|
artikel
|
| 11 |
Introduction: Open questions on the endocrinology of daily clinical practice in ovarian stimulation
|
Ludwig, Michael
|
|
2005
|
11 |
5 |
p. 554-
1 p.
|
artikel
|
| 12 |
Italian law on assisted conception: clinical and research implications
|
Manna, Claudio
|
|
2005
|
11 |
5 |
p. 532-534
3 p.
|
artikel
|
| 13 |
IUI in male subfertility: are we able to select the proper patients?
|
van Weert, Janne-Meije
|
|
2005
|
11 |
5 |
p. 624-631
8 p.
|
artikel
|
| 14 |
Oxidative stress and its implications in female infertility – a clinician's perspective
|
Agarwal, Ashok
|
|
2005
|
11 |
5 |
p. 641-650
10 p.
|
artikel
|
| 15 |
Pharmacogenetics in ovarian stimulation – current concepts and future options
|
Greb, Robert R
|
|
2005
|
11 |
5 |
p. 589-600
12 p.
|
artikel
|
| 16 |
Professor Takahide Mori
|
|
|
2005
|
11 |
5 |
p. 531-
1 p.
|
artikel
|
| 17 |
Recombinant follicle-stimulating hormone: gold standard or not?
|
Out, Henk J
|
|
2005
|
11 |
5 |
p. 536-539
4 p.
|
artikel
|
| 18 |
Recombinant gonadotrophins in reproductive medicine: a viewpoint from India
|
Kumar, TC Anand
|
|
2005
|
11 |
5 |
p. 543-544
2 p.
|
artikel
|
| 19 |
Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century
|
Ludwig, M
|
|
2005
|
11 |
5 |
p. 535-536
2 p.
|
artikel
|
| 20 |
Recombinant or urinary gonadotrophins – an Australian perspective
|
Norman, RJ
|
|
2005
|
11 |
5 |
p. 542-543
2 p.
|
artikel
|
| 21 |
Respective efficacy of gonadotrophins should be the heart of the debate
|
Emperaire, JC
|
|
2005
|
11 |
5 |
p. 540-542
3 p.
|
artikel
|
| 22 |
Successful pregnancy following transfer of embryos from oocytes with abnormal zona pellucida and cytoplasm morphology
|
Esfandiari, Navid
|
|
2005
|
11 |
5 |
p. 620-623
4 p.
|
artikel
|
| 23 |
Ten years of Swiss National IVF Register FIVNAT-CH. Are we making progress?
|
Van den Bergh, Marc
|
|
2005
|
11 |
5 |
p. 632-640
9 p.
|
artikel
|
| 24 |
The embryologist as counsellor during assisted reproduction procedures
|
van Zyl, Cornelia
|
|
2005
|
11 |
5 |
p. 545-551
7 p.
|
artikel
|
Tijdschrift beschrijving